News
Subscribe to our monthly newsletter to receive exclusive news updates and medical AI insights. SubscribeFeatured News
The Value of Deep Learning-based CT-FFR in Detecting Coronary Stenosis & Predicting Outcomes
Researchers at Fuwai Hospital conducted a retrospective study to evaluate the performance of Keya Medical’s deep learning-based CT-FFR product in detecting hemodynamic changes in stenosis.
Putting the Spotlight on Women’s Hearts: Cardiovascular Disease in Women
Cardiovascular disease (CVD) remains the leading cause of death for women in the U.S. In honor of American Heart Month, we are highlighting the differences in women’s risk factors and primary prevention to help manage CVD in women.
Will New Value-based Care Regulations Spark Innovation?
On Jan. 19, two regulatory changes went into effect that intend to modernize the Physician Self-Referral Statute & the Anti-Kickback Statute, facilitating the shift to value-based care.
Keya Medical Raises $46M in Series D Round
Keya Medical has raised $46 million in Series D funding. This funding round was led by new and existing investors, including CICC Capital, Shanghai Artificial Intelligence Investment Fund, Qianhai Gaozu Asset Management Fund, and IN CAPITAL.
EACVI Best of Imaging: Advances in Cardiac CT
EACVI Best of Imaging introduced the latest advances in cardiac CT, promoting a patient-centric, multi-modality approach to cardiovascular disease diagnosis.
Keya Medical Closes $30 Million Series C Funding Round Led by IDG Capital
Keya Medical announced that it has completed a $30 Million Series C Funding Round led by IDG Capital, with participation from investors Alwin Capital, Source Code Capital, and Tasly Group.
Virtual Medical AI Events in November
We have compiled a list of free virtual events hosted by professional organizations that will take place in November, covering topics in cardiology, radiology, and AI.
Coronary CTA Reimbursement: Opportunities & Challenges
Examine the current challenges for coronary CTA reimbursement, the potential effects it will have on patient care, and what medical imagers can do to help improve reimbursement moving forward.
Keya Medical Awarded China Health Innovation Award at 2020 DEMO China
On Oct. 17 and 18, the Chengdu Science and Technology Bureau hosted the 2020 DEMO China Innovation Finals, bringing together leading companies across the country.
QICCD 2020: Diagnosis and Treatment of Cardiovascular Disease
Dr. Kunlin Cao, President of Keya Medical R&D, participated in the Cardiovascular Disease Imaging Forum at QICCD 2020 alongside Dr. Pengfei Zhang of Shangdong University.
Keya Medical Presents at the Second Congress of China AI in Medical Imaging Conference
Dr. Kunlin Cao delivered a keynote address at the China AI in Medical Imaging Conference on Keya Medical’s experience bringing AI-powered medical imaging solutions to clinical use.
Innovation Fast and Slow: The Case for Coronary CT Angiography
Recent research demonstrates applications for CCTA to be used as the default test for evaluating patients with stable chest pain.
Keya Medical Wins 2020 Ernst & Young Fudan China’s Most Promising Company Award
On Sept. 18, Keya Medical was recognized as the winner of China’s Most Promising Company award because of its leading R&D team and innovative cardiovascular product line.
